Of course they all want to see CD12 data
Nothing new here from my initial expectations. CD12 is set up like a dangling carrot...forward.
The thing is, that data is coming....at Warp Speed. And it will answer ALL questions the FDA or the UK may have.
As a side note, Remdesevir had less than m/m to show for and it got approved. Why is LL held up against a higher standard? News2 should be enough. But, whats a few weeks more if the CD12 is the flood gate that gets both indications approved...really. Its playing out as expected, and both indications will get approved once CD12 data is released.